88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

2025 AACR \| Abbisko Therapeutics Presents Late-Breaking Pre-clinical Research Results on ABSK112 (EGFR exon20ins), ABSK131 (PRMT5*MTA), and ABK-KRAS-1 SHANGHAI , April 28, 2025 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics 02256.HK ) today announced that it has presented four late-breaking pre-clinical research posters ... 2025-04-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ImmVira Presented Clinical Results of Oncolytic Product MVR-C5252 Targeting Malignant Glioma via Convection-Enhanced Delivery at 2025 AACR Annual Meeting SUZHOU, China , April 28, 2025 /PRNewswire/ -- From April 25 to April 30, 2025 , U.S. time, ImmVira presented the Phase I clinical results of its oncolytic Herpes Simplex Virus (" oHSV ") ... 2025-04-28T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Nona Biosciences' Partner Pfizer Presents Preclinical Data on TOP1i-Based ADC Targeting MSLN at AACR Annual Meeting 2025 CAMBRIDGE, Mass. , April 28, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I TM ), today announced that ... 2025-04-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
2025 AACR \| Innovent Presents Preclinical Data of Multiple Novel Molecules including Bispecific and Tri-specific Antibodies and Bispecific ADCs SAN FRANCISCO and SUZHOU, China , April 28, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ... 2025-04-28T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ONO PHARMA USA Announces 2025 Golden Ticket CompetitionNow Accepting Applications from Innovative Startups Ono Partnering with LabCentral and MBC BioLabs for Fifth Consecutive Year ... 2025-04-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene Presents Four Posters at AACR 2025 Highlighting Focuses on AnTenGagerTM TCEs and Synthetic Lethality SHANGHAI and HONG KONG , April 26, 2025 /PRNewswire/ -- Antengene Corporation Limited (" Antengene ", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company ... 2025-04-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Solid Tumors CHENGDU, China , April 25, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced CM518D1, a CDH17-targeted antibody-drug ... 2025-04-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Announcement of Paper Publication: EditForce Demonstrates Efficacy of Treatment for Myotonic Dystrophy Type 1 Using PPR Platform Technology FUKUOKA, Japan , April 25, 2025 /PRNewswire/ -- EditForce, Inc. (Headquarters: Fukuoka, Japan ) is pleased to announce that a research paper on the results of a joint study with the research group ... 2025-04-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals Publishing/Information Service
Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Gastrointestinal Cancers CHENGDU, China , April 25, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") recently announced CM518D1, a CDH17-targeted antibody-drug ... 2025-04-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Akeso Announces FDA Approval for Penpulimab-kcqx in Two BLA Indications for Comprehensive Treatment of Advanced Nasopharyngeal Carcinoma HONG KONG , April 25, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the U.S. Food and Drug Administration (FDA) has approved its ... 2025-04-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2025

Suntek Computer Systems Limited.

All rights reserved